Development and validation of an efficient HPLC method for quantification of voriconazole in plasma and microdialysate reflecting an important target site
Authors:
- 3 August 2008
- journal article
- research article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 392 (3) , 479-488
Abstract
Voriconazole is a very potent antifungal agent used to treat serious fungal infections (candidiasis); it is also the therapy of choice for aspergillosis. After standard dosing, several factors affect exposure of voriconazole, resulting in large variability and demanding further elucidation of drug distribution. For measurements at the site of action, microdialysis is considered to be an outstanding minimally invasive method. For determination of voriconazole in microdialysate and human plasma a new, efficient, reliable, and robust HPLC assay using UV detection at 254 nm has been developed and validated. After simple sample preparation using acetonitrile for plasma and for microdialysate, 20 μL were injected and separated on an RP-18 column. The chromatographic run time was less than 4 min. Overall, the assay showed high precision (CV 93.9 to 99.5%) and accuracy (RE −96.7 to +107%) for both matrices. Of the 36 drug products typically co-administered with voriconazole, none except ambroxol interfered with its peak signal, and this interference was successfully managed. In summary, the method is highly suitable for application in (pre)clinical microdialysis studies, e.g., of critically ill patients with invasive mycoses. Microdialysis probe situated in the interstitial space fluid containing voriconazole drug molecules (magenta coloured) extracting an important target site representative matrix (microdialysate) [Courtesy of CMA]Keywords
This publication has 27 references indexed in Scilit:
- The Pharmacokinetic Profile of Voriconazole During Continuous High-volume Venovenous Hemofiltration in a Critically Ill PatientTherapeutic Drug Monitoring, 2008
- Variability of Voriconazole Plasma Levels Measured by New High-Performance Liquid Chromatography and Bioassay MethodsAntimicrobial Agents and Chemotherapy, 2007
- Voriconazole Therapeutic Drug MonitoringAntimicrobial Agents and Chemotherapy, 2006
- Pharmacokinetic/Pharmacodynamic Profile of VoriconazoleClinical Pharmacokinetics, 2006
- Microdialysis—theoretical background and recent implementation in applied life-sciencesEuropean Journal of Pharmaceutical Sciences, 2005
- Newer Systemic Antifungal AgentsDrugs, 2004
- The pharmacokinetics and safety of intravenous voriconazole – a novel wide‐spectrum antifungal agentBritish Journal of Clinical Pharmacology, 2003
- Voriconazole Concentrations in the Cerebrospinal Fluid and Brain Tissue of Guinea Pigs and Immunocompromised PatientsClinical Infectious Diseases, 2003
- Pharmacokinetics and Safety of Voriconazole following Intravenous- to Oral-Dose Escalation RegimensAntimicrobial Agents and Chemotherapy, 2002
- Science, medicine, and the future: MicrodialysisBMJ, 2002